Home General Biotechnology Drug Patent Expirations in October 2011

Drug Patent Expirations in October 2011

Drug Patent Expirations in October 2011

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
ZOLINZAMerckvorinostat6,087,367Oct 4, 2011
ZORBTIVEEmd Seronosomatropin recombinant5,288,703Oct 7, 2011
NUTRESTOREEmmaus Medclglutamine5,288,703Oct 7, 2011
ATACANDAstrazenecacandesartan cilexetil7,538,133*PEDOct 18, 2011
ATACAND HCTAstrazenecacandesartan cilexetil; hydrochlorothiazide7,538,133*PEDOct 18, 2011
ATACANDAstrazenecacandesartan cilexetil5,705,517*PEDOct 18, 2011
ATACAND HCTAstrazenecacandesartan cilexetil; hydrochlorothiazide5,705,517*PEDOct 18, 2011
ELIGARDTolmar Therapleuprolide acetate5,324,519Oct 20, 2011
SYMBYAXLillyfluoxetine hydrochloride; olanzapine5,229,382*PEDOct 23, 2011
ZYPREXA RELPREVVEli Lilly Coolanzapine pamoate5,229,382*PEDOct 23, 2011
ZYPREXALillyolanzapine5,627,178*PEDOct 23, 2011
ZYPREXALillyolanzapine5,817,656*PEDOct 23, 2011
ZYPREXALillyolanzapine5,817,657*PEDOct 23, 2011
ZYPREXALillyolanzapine5,817,655*PEDOct 23, 2011
ZYPREXALillyolanzapine5,229,382*PEDOct 23, 2011
ZYPREXA ZYDISLillyolanzapine5,229,382*PEDOct 23, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com

NO COMMENTS

Leave a Reply